Affiliation: Duke University Medical Center
- Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancerDeanna Teoh
Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA
Gynecol Oncol 122:467-72. 2011..To evaluate the costs and effectiveness of thromboprophylaxis strategies following laparotomy for ovarian cancer...
- Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancerDeanna Teoh
Division of Gynecologic Oncology, Duke Cancer Institute, Durham, NC, USA
Int J Gynecol Cancer 22:348-59. 2012....
- Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cellsDeanna Teoh
Division of Gynecologic Oncology, Duke Comprehensive Cancer Center, Durham, NC 27710, USA
Gynecol Oncol 121:187-92. 2011..To explore the activity of dasatinib alone and in combination with paclitaxel and carboplatin in ovarian cancer cells and to determine if dasatinib activity can be predicted based on evaluation of the SRC pathway...